MDM2 and glioblastoma: As GBM cells typically express p53 with a wild-type amino acid sequence, the re-activation of p53 functionality can be restored through the inhibition of the oncogenic block exerted by the AKT/mTOR pathway, which causes an excessive stimulation of MDM2.